2. UroToday Home
  3. Video Lectures

Artificial Intelligence in Prostate Cancer Videos

AI-Powered Prostate Cancer Risk Assessment Tool Validated for Low-risk and Active Surveillance - Andre Esteva
October 17, 2024
Details
PROSTATE-IQ Trial: Reducing ADT Burden in Salvage Radiotherapy - Karen Hoffman
June 27, 2024
Details
Prognostic Power of Multi-Modal Artificial Intelligence Biomarker in CHAARTED Trial Subset - Mark Markowski
June 12, 2024
Details
Optimizing Salvage Radiation Therapy in Prostate Cancer: New AUA/ASTRO/SUO Guideline - Todd Morgan
May 14, 2024
Details
Predicting Response to Hormone Therapy in Prostate Cancer With a Post-Prostatectomy MMAI Model - Todd Morgan
May 14, 2024
Details
NCCN 2024 Guidelines Endorse Novel Prostate Test for Precision Risk Stratification - Rashid Sayyid & Zachary Klaassen
April 3, 2024
Details
Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer - Gerhardt Attard
November 20, 2023
Details
The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript
June 29, 2023
Details
Personalizing Prostate Cancer Therapy Using AI-based Predictive Biomarkers - Paul Nguyen
June 14, 2023
Details
Artera Multi-Modal AI Platform - Guiding Treatment Decisions in Men with Prostate Cancer - Andre Esteva & Felix Feng
March 22, 2023
Details
Beyond the NCCN Localized Prostate Cancer Risk Category: The MMAI Prognostic Risk Stratification Model - Jonathan Tward
March 13, 2023
Details
Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer - Daniel Spratt
March 10, 2023
Details
Artificial Intelligence Transformative in Prostate Cancer Patient Care - Felix Feng
February 8, 2023
Details
Who is ARTERA? - Andre Esteva
January 22, 2023
Details
Beyond Genomics: AI Informing Decision Making in Prostate Cancer – Ashley Ross
January 22, 2023
Details